About 50% of menopausal women experience genitourinary syndrome of menopause (GSM) that involves changes to the genitals, ...

Adding Kisqali (ribociclib) to a nonsteroidal aromatase inhibitor helped patients with hormone receptor–positive, HER2-negative early breast cancer live longer without their disease returning, ...

Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to ...

Hone Health reports that doctors are reconsidering hormone therapy for breast cancer survivors, suggesting safe options may exist despite previous guidelines.

Eli Lilly has won the second FDA approval for an oral selective estrogen receptor degrader (SERD). Like the first oral SERD, Lilly’s imlunestrant is only cleared to treat ER-positive, HER2-negative ...

Findings showed denosumab-kyqq demonstrated similar quality, safety, and efficacy to the reference product. Bosaya is approved to treat postmenopausal women with osteoporosis at high risk for fracture ...

Tara Bannow covers hospitals, providers, and insurers. You can reach Tara on Signal at tarabannow.70. Parents of kids with autism might soon flock to a dietary supplement with the same key ingredient ...

Supplements can have health benefits, but they do not require the same rigorous testing and approval as prescription medications. Buyers can look for certifications and read labels for signs of ...

Bildyos is supplied as a 60mg/mL single-dose prefilled syringe and single-dose vial; Bilprevda is supplied as a 120mg/1.7mL single-dose vial. Bildyos is approved to treat postmenopausal women with ...

Andrew Huberman predicts the next breakthrough supplement and explains the key health benefits that could make it a game-changer. Now, Huberman is diving into a look at what could lie ahead in the ...

These 13 foods and supplements may increase your risk of foodborne illness, interact with your cancer medications, or worsen treatment side effects. Nutrition plays an important role in cancer ...

Shanghai Henlius Biotech and Organon have received permission from the Food and Drug Administration for Bildyos (denosumab-nxxp) injection 60 mg/ml and Bilprevda (denosumab-nxxp) injection 120 mg/1.7 ...